Drug Resistance
NovaBay Pharmaceuticals (NBY) Publishes on the Design of New Class of Antimicrobial Compounds It Named Aganocides(TM)
Published in Virus Weekly, April 1st, 2008
Researchers at NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY, www.novabaypharma.com), a biopharmaceutical company developing products for the treatment or prevention of a wide range of bacterial, fungal and viral infections, have published a seminal paper on the design and synthesis of a new class of stable antimicrobial compounds. The company believes that these compounds, trademarked as Aganocides, have the potential to become a new weapon in the fight against such deadly pathogens as methicillin-resistant Staphylococcus aureus (MRSA). NovaBay is currently conducting human clinical trials of its lead Aganocide compound in two indications.
Known as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (2008-04-01)
More Articles from Virus Weekly
- Bird Flu
Reports from University of Marmara, Medical Department add new data to research in bird flu - Fibromyalgia
Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia - Hantavirus
Research by J.R. Levine and colleagues in hantavirus provides new insights - Herpesvirus
New herpesvirus research reported from C.S. Gibson and co-authors - Infectious Pancreatic Necrosis Virus
Study results from Lund University in the area of infectious pancreatic necrosis virus published - Leishmaniasis
Findings from I. Ramos and co-authors provide new insights into leishmaniasis - More from this issue of Virus Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
